ImmuCell
ICCC
29 hedge funds and large institutions have $7.04M invested in ImmuCell in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 28 → 29 (+1)
0.23% more ownership
Funds ownership: 11.15% → 11.37% (+0.23%)
13% less capital invested
Capital invested by funds: $8.05M → $7.04M (-$1.01M)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$179K |
| 2 |
HPC
HM Payson & Co
Portland,
Maine
|
+$54.8K |
| 3 |
Morgan Stanley
New York
|
+$32.2K |
| 4 |
BL
Bleichroeder LP
New York
|
+$14.7K |
| 5 |
BlackRock
New York
|
+$5.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$89.3K |
| 2 |
Renaissance Technologies
New York
|
-$77.8K |
| 3 |
OMC
Overbrook Management Corp
New York
|
-$59.5K |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$14K |
| 5 |
EFS
Essex Financial Services
Essex,
Connecticut
|
-$11.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $2K | – | – | – |
|
27
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $1K | +$893 | +100 | New |
|
|
OSAM
29
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$14K | -1,443 | Closed |
|
|
HI
30
Harbour Investments
Madison,
Wisconsin
| – | -$2K | -250 | Closed |
|
ICCC Hedge Fund Activity: Q4 2021 in Review
29 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2021, worth a combined $7.04M — down 13% from $8.05M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ICCC positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $179K. The largest seller was Perritt Capital Management, cutting an estimated $89.3K.
- 29 institutional investors held ImmuCell (ICCC) as of Q4 2021, up from 28 in Q3 2021.
- Funds reported $7.04M of ImmuCell stock for Q4 2021, down 13% quarter-over-quarter.
- 3 funds opened new ImmuCell positions in Q4 2021 and 2 closed out, a net change of +1 holder.
- The largest ImmuCell buyer in Q4 2021 was Vanguard Group, an estimated $179K added.
- The largest ImmuCell seller in Q4 2021 was Perritt Capital Management, an estimated $89.3K sold.
Based on aggregated 13F filings for Q4 2021.